Like this one rejected by Qiagen SH recently? US$12.5 billion, it’s actually WTF, on a Thermofisher offer. I’m not sure diagnostic tests are so popular in Biotech investment. A lot in Pharma news & a BIG deal:
https://www.thepharmaletter.com/article/qiagen-shareholders-vote-down-thermo-fisher-takeover-attempt
It was a minnow in the big scheme of things when we first started discussion on this stock (Qiagen), & then COVID-19. PIQ have some comparison. DYOR
Ann: PromarkerD Intellectual Property portfolio expands, page-53
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.03 |
Change
0.005(0.49%) |
Mkt cap ! $134.2M | |||
| Open | High | Low | Value | Volume |
| $1.03 | $1.06 | $1.00 | $134.2K | 131.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3987 | $1.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.03 | 4762 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |